Company intelligence / Profile preview

Robovision

Ghent, East Flanders, Belgiumrobovision.ai ↗

Ownership: Private
Employees: ~130
Development stage: Commercial

Overview

Robovision has demonstrated the ability to deploy its computer vision AI across agriculture, manufacturing, and healthcare. In life sciences, its technology was adapted from plant disease detection to human lung disease detection during COVID. The company’s solutions are commercially deployed globally with over 1,000 active licenses in more than 40 countries.

Therapeutic areas: Other
Modalities: Device
Industry: Digital Health Medical Devices

Partnerships

ISO Group

Beyond the preview

Go deeper on Robovision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Robovision.

Explore the full profile